Premium
Consensus statements on the clinical uses of pregabalin for Hong Kong
Author(s) -
Kwong Patrick PoKeung,
Chan Eric YanKwong,
Cheung Eric YatWo,
Fong Samson YatYuk,
Nip Wai,
Cheung Henry HonKee,
Yip Isaac PuiLam,
Chong KingYee,
Pao Ronnie SzeYuan,
Tam KaLok,
Tang ManHo,
Chan Simon KinCheong,
Mak KiYan
Publication year - 2020
Publication title -
asia‐pacific psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.654
H-Index - 21
eISSN - 1758-5872
pISSN - 1758-5864
DOI - 10.1111/appy.12403
Subject(s) - pregabalin , set (abstract data type) , anxiety , voting , alternative medicine , medicine , medline , psychology , family medicine , medical education , psychiatry , computer science , political science , programming language , pathology , politics , law
To facilitate the understanding of pregabalin and optimize its clinical usage in Hong Kong, an expert panel (11 psychiatrists, one family physician and one anesthesiologist) experienced in treating anxiety and somatic symptoms was invited to establish a set of consensus statements based on several discussion areas. A non‐systematic literature search for relevant articles was conducted. The panelists addressed the discussion areas by sharing their clinical experience and available literature in a couple of meetings. At the last meeting, consensus statements derived from the proceedings were discussed and finalized. A total of 11 statements were ultimately accepted by panel voting based on their practicability of recommendation in Hong Kong. These statements are aimed to act as a practical reference for local clinicians when they consider prescribing pregabalin in different clinical situations.